peroxynitrous acid has been researched along with okadaic acid in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (okadaic acid) | Trials (okadaic acid) | Recent Studies (post-2010) (okadaic acid) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 3,865 | 2 | 658 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamisaki, Y; Maeda, S; Saeki, M | 1 |
1 other study(ies) available for peroxynitrous acid and okadaic acid
| Article | Year |
|---|---|
Vanadate protects human neuroblastoma SH-SY5Y cells against peroxynitrite-induced cell death.
Topics: Cell Death; Crk-Associated Substrate Protein; Cyclosporine; Enzyme Inhibitors; Humans; Molsidomine; Neuroblastoma; Nitric Oxide Donors; Okadaic Acid; Peroxynitrous Acid; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Protein Tyrosine Phosphatases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-crk; Retinoblastoma-Like Protein p130; Signal Transduction; Tumor Cells, Cultured; Vanadates | 2002 |